Get Full Government Meeting Transcripts, Videos, & Alerts Forever!
DLS: Maryland's FY27 capital plan shrinks to $2.6B as bond proceeds plug operating gaps
Summary
DLS analysts told the Capital Budget Subcommittee the FY27 capital program falls to about $2.6 billion as transfers, bond proceeds and deauthorizations are used to cover operating shortfalls; the Baltimore Therapeutic Treatment Center was paused and WMATA grant funding is being shifted to bond financing.
Delegate Malcolm Ruff convened the Capital Budget Subcommittee hearing and invited DLS analysts to review the governor's FY27 capital plan. DLS presented a five‑year capital overview showing the total program decreases to roughly $2.6 billion and that the general obligation (GO) bond authorization meets the spending affordability limit of $1.75 billion.
DLS analyst Emily Haskell said the budget relies in part on deauthorizing prior‑year projects to create about $75 million in GO capacity and includes roughly $58 million in PayGo/general funds. Haskell also noted a $14.6 million first installment of an eight‑year, $116.5 million commitment tied to an expansion of AstraZeneca facilities.
Matt Bennett of DLS…
Already have an account? Log in
Subscribe to keep reading
Unlock the rest of this article — and every article on Citizen Portal.
- Unlimited articles
- AI-powered breakdowns of topics, speakers, decisions, and budgets
- Instant alerts when your location has a new meeting
- Follow topics and more locations
- 1,000 AI Insights / month, plus AI Chat
